Weiyi Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Weiyi Liu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Greg F. Walker
School of Pharmacy, University of Otago, Dunedin 9016, New Zealand
2 shared publications - Sally Price
Faculty of Agriculture and Life Sciences, Lincoln University, Lincoln 7647, New Zealand
2 shared publications - Craig Bunt
Department of Food Science, Otago University, Dunedin 9054, New Zealand
1 shared publication - Craig Robert Bunt
Lincoln University
1 shared publication Cunyi Zhao
Department of Biological and Agricultural Engineering, University of California, Davis, CA 95616, USA
1 shared publication- Grant Bennett
Agriculture and Life Sciences Division, PO Box, Lincoln University, Lincoln 7647, New Zealand
1 shared publication
Latest Publications
- 18 June 2022
- Published by Elsevier in Journal of Controlled Release
- Vol. 348, 612-630
A landscape review of controlled release urea products: Patent objective, formulation and technology
- 18 June 2022
- Published by Elsevier in Journal of Controlled Release
- Vol. 348, 612-630
A landscape review of controlled release urea products: Patent objective, formulation and technology
- Open Access
- 21 June 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (6) , 916
Electrospun Membranes as a Porous Barrier for Molecular Transport: Membrane Characterization and Release Assessment
Electrospun nanofibers have been extensively studied for encapsulated drugs releasing from the inside of the fiber matrix, but have been barely looked at for their potential to control release as a semi-permeable membrane. This study investigated molecular transport behaviors across nanofiber membranes with different micro-structure sizes and compositions. Four types of membranes were made by 5% and 10% poly (ε-caprolactone) (PCL) solutions electro-spun with or without 50 nm calcium carbonate (CaCO3) nanoparticles. The membranes were tested for thickness, fiber diameter, pore size, porosity, tensile strength and elongation, contact angle of water and their impacts on molecular transport behaviors. The presence of the CaCO3 nanoparticles made the 5% membranes stronger and stiffer but the 10% membranes weaker and less stiff due to the different (covering or embedded) locations of the nanoparticles with the corresponding fibers. Solute transport studies using caffeine as the model drug found the 5% membranes further retarded release from the 10% membranes, regardless of only half the amount of material being used for synthesis. The addition of CaCO3 nanoparticles aided the water permeation process and accelerated initial transports. The difference in release profiles between 5% and 10% membranes suggests different release mechanisms, with membrane-permeability dominated release for 5% PCL membranes and solute-concentration-gradient dominated release for 10% PCL membranes.
- 21 June 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (6) , 916
Open AccessElectrospun Membranes as a Porous Barrier for Molecular Transport: Membrane Characterization and Release Assessment
Electrospun nanofibers have been extensively studied for encapsulated drugs releasing from the inside of the fiber matrix, but have been barely looked at for their potential to control release as a semi-permeable membrane. This study investigated molecular transport behaviors across nanofiber membranes with different micro-structure sizes and compositions. Four types of membranes were made by 5% and 10% poly (ε-caprolactone) (PCL) solutions electro-spun with or without 50 nm calcium carbonate (CaCO3) nanoparticles. The membranes were tested for thickness, fiber diameter, pore size, porosity, tensile strength and elongation, contact angle of water and their impacts on molecular transport behaviors. The presence of the CaCO3 nanoparticles made the 5% membranes stronger and stiffer but the 10% membranes weaker and less stiff due to the different (covering or embedded) locations of the nanoparticles with the corresponding fibers. Solute transport studies using caffeine as the model drug found the 5% membranes further retarded release from the 10% membranes, regardless of only half the amount of material being used for synthesis. The addition of CaCO3 nanoparticles aided the water permeation process and accelerated initial transports. The difference in release profiles between 5% and 10% membranes suggests different release mechanisms, with membrane-permeability dominated release for 5% PCL membranes and solute-concentration-gradient dominated release for 10% PCL membranes.